Antenatal Seroprevalence of Zika and Chikungunya Viruses, Kingston Metropolitan Area, Jamaica, 2017-2019

To determine the extent of exposure to Zika virus (ZIKV) and chikungunya virus (CHIKV) in Jamaica, we collected serum from 584 pregnant women during 2017-2019. We found that 15.6% had antibodies against ZIKV and 83.6% against CHIKV. These results indicate potential recirculation of ZIKV but not CHIK...

Full description

Saved in:

Bibliographic Details
Published in:	Emerging infectious diseases Vol. 28; no. 2; pp. 473 - 475
Main Authors:	Anzinger, Joshua J, Mears, Chadwic D, Ades, A E, Francis, Keisha, Phillips, Yakima, Leys, Ynolde E, Spyer, Moira J, Brown, David, de Filippis, Ana M Bispo, Nastouli, Eleni, Byrne, Thomas, Bailey, Heather, Palmer, Paulette, Bryan, Lenroy, Webster-Kerr, Karen, Giaquinto, Carlo, Thorne, Claire, Christie, Celia D C
Format:	Journal Article
Language:	English
Published:	United States U.S. National Center for Infectious Diseases 01-02-2022 Centers for Disease Control and Prevention
Subjects:	antenatal Antenatal Seroprevalence of Zika and Chikungunya Viruses, Kingston Metropolitan Area, Jamaica, 2017–2019 Antibodies Blood & organ donations Chikungunya fever Chikungunya Fever - epidemiology Chikungunya virus Dengue Dengue fever Epidemics Epidemiology Female Health aspects Hospitals Humans Infections Infectious diseases Jamaica - epidemiology Kingston Metropolitan Area Pregnancy Pregnant women prevalence Research Letter Risk factors Seroepidemiologic Studies Statistics vector-borne infections Womens health Zika Virus Zika Virus Infection - epidemiology Jamaica Puerto Rico United Kingdom > UK United States > US Guadeloupe Martinique Suriname prevalence Kingston Metropolitan Area viruses vector-borne infections antenatal Zika virus chikungunya virus Caribbean Jamaica
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To determine the extent of exposure to Zika virus (ZIKV) and chikungunya virus (CHIKV) in Jamaica, we collected serum from 584 pregnant women during 2017-2019. We found that 15.6% had antibodies against ZIKV and 83.6% against CHIKV. These results indicate potential recirculation of ZIKV but not CHIKV in the near future.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This project was funded from the Horizon 2020: EU Programme for Research and Innovation under grant agreement no. 734857.
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid2802.211849